A Phase II Open Label, Multi-Center Study With AVR118 in Anorectic Patients With Recurrent or Advanced Malignancies
NCT00765466
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
30
Enrollment
OTHER
Sponsor class
Stopped
Study transferred out of McGill because PI relocted to another insitution.
Conditions
Cancer
Interventions
DRUG:
AVR118
Sponsor
McGill University